Under pressure to boost production of Covid-19 drug remdesivir, Gilead inks pact with Pfizer

The deal is the latest to help Gilead boost production of one of the few drug weapons against Covid-19.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.